Bank of America Corp DE Has $100,000 Stake in 22nd Century Group Inc (XXII)

Bank of America Corp DE trimmed its holdings in shares of 22nd Century Group Inc (NYSEAMERICAN:XXII) by 39.1% in the second quarter, according to its most recent filing with the SEC. The firm owned 40,585 shares of the biotechnology company’s stock after selling 26,075 shares during the period. Bank of America Corp DE’s holdings in 22nd Century Group were worth $100,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in the company. BlackRock Inc. increased its position in shares of 22nd Century Group by 162.0% during the 2nd quarter. BlackRock Inc. now owns 7,361,866 shares of the biotechnology company’s stock worth $18,110,000 after purchasing an additional 4,551,911 shares in the last quarter. State Board of Administration of Florida Retirement System acquired a new stake in shares of 22nd Century Group during the 2nd quarter worth about $167,000. Schwab Charles Investment Management Inc. increased its position in shares of 22nd Century Group by 766.5% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 244,973 shares of the biotechnology company’s stock worth $603,000 after purchasing an additional 216,700 shares in the last quarter. Bank of New York Mellon Corp increased its position in shares of 22nd Century Group by 200.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 337,281 shares of the biotechnology company’s stock worth $830,000 after purchasing an additional 225,039 shares in the last quarter. Finally, NJ State Employees Deferred Compensation Plan acquired a new stake in shares of 22nd Century Group during the 2nd quarter worth about $418,000.

Shares of 22nd Century Group stock opened at $3.04 on Monday. 22nd Century Group Inc has a 12-month low of $1.92 and a 12-month high of $4.44.

22nd Century Group (NYSEAMERICAN:XXII) last announced its earnings results on Wednesday, November 7th. The biotechnology company reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $6.26 million for the quarter.

A number of brokerages recently issued reports on XXII. Zacks Investment Research cut shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research report on Thursday, August 16th. TheStreet upgraded shares of 22nd Century Group from a “d” rating to a “c-” rating in a research report on Monday, November 26th.

ILLEGAL ACTIVITY NOTICE: This report was published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.com-unik.info/2018/12/03/bank-of-america-corp-de-has-100000-stake-in-22nd-century-group-inc-xxii.html.

22nd Century Group Company Profile

22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies.

Recommended Story: Diversification For Individual Investors

Want to see what other hedge funds are holding XXII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 22nd Century Group Inc (NYSEAMERICAN:XXII).

Institutional Ownership by Quarter for 22nd Century Group (NYSEAMERICAN:XXII)

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit